Skip to main content
FinSpry Logo
FinSpry
HBIO logo
HBIO
(NASDAQ)
Harvard Bioscience, Inc.
$5.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Harvard Bioscience (HBIO) Stock Price & Financial Analysis

Harvard Bioscience Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.00 - $5.27
52-Week High$8.40
52-Week Low$0.28
Open$5.00
Volume31.04K
Average Volume (3M)31.04K
Market Cap230.83M
Shares Outstanding44.39M
Price to Sales (P/S)2.61
EV/EBITDA-3.86
Revenue (TTM)86.55M
Net Income (TTM)-56.70M
Free Cash Flow (TTM)5.02M
EPS (TTM)$-1.28
Profit Margin-65.51%
Operating Margin-0.14%
50-Day MA$5.42
200-Day MA$2.45
52-Week Change762.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Harvard Bioscience

What is the current stock price for HBIO?

As of the latest trading session, HBIO stock trades at $5.20. The 52-week range is $0.28–$8.40, with a day range of $5.00–$5.27.

What is the P/E ratio for HBIO?

The P/E ratio (Price-to-Earnings) for HBIO is shown in the Key Statistics section. This valuation metric helps compare Harvard Bioscience, Inc. to industry peers.

Does HBIO pay dividends?

Harvard Bioscience does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HBIO?

Based on 1 analyst, the consensus for HBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HBIO?

Harvard Bioscience's market capitalization is $230.8M, classifying it as a micro-cap company. Harvard Bioscience operates in the Healthcare sector within the Medical Instruments & Supplies industry.